<- Go Home
Inotiv, Inc.
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Market Cap
$79.6M
Volume
452.7K
Cash and Equivalents
$38.0M
EBITDA
-$4.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$102.7M
Profit Margin
21.62%
52 Week High
$7.77
52 Week Low
$1.23
Dividend
N/A
Price / Book Value
0.47
Price / Earnings
-0.51
Price / Tangible Book Value
-0.42
Enterprise Value
$488.7M
Enterprise Value / EBITDA
76.64
Operating Income
-$61.5M
Return on Equity
56.93%
Return on Assets
-4.78
Cash and Short Term Investments
$38.0M
Debt
$447.1M
Equity
$169.8M
Revenue
$475.1M
Unlevered FCF
$46.0M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium